神经精神性系统性红斑狼疮患者B细胞与补体级联基因特征增强
对308例系统性红斑狼疮患者(119例神经精神性、189例非神经精神性)及72名匹配健康对照进行全血RNA测序,发现神经精神性患者适应性免疫应答失调及IL-1、IL-6、IL-17、IL-12/IL-23信号通路上调,且B细胞与补体级联特征在非神经精神性、非活动性神经精神性、活动性神经精神性亚组中逐步上调。
要点
- 神经精神性较非神经精神性患者补体级联、DNA损伤应答、适应性免疫及IL-1、IL-6信号显著上调。
- 活动性神经精神性患者呈现强自噬特征,B细胞与补体特征随疾病活动度逐步上调。
- 不同神经精神性内型(认知障碍、癫痫、精神病、视神经炎)对应不同转录组特征。
核心结论
- 神经精神性系统性红斑狼疮的临床异质性似乎与分子多样性相关,某些内型或综合征表现出不同的基因特征。
- 适应性免疫应答和补体级联的上调提示补体抑制剂和B细胞靶向治疗可在神经精神性系统性红斑狼疮中进一步探索。
研究设计与样本
- 对308例系统性红斑狼疮患者(119例神经精神性、189例非神经精神性)及72名匹配健康对照进行全血RNA测序。
- 采用监督通路富集分析和无监督加权基因共表达网络分析区分临床和分子定义的神经精神性内型。
主要发现
- 与健康对照相比,神经精神性患者适应性免疫应答失调,伴IL-1、IL-6、IL-17和IL-12/IL-23信号通路上调。
- 神经精神性组与非神经精神性组比较显示补体级联、DNA损伤应答、适应性免疫及IL-1和IL-6信号显著上调。
- 活动性神经精神性患者表现出强自噬特征。
- B细胞和补体级联特征在非神经精神性、非活动性神经精神性、活动性神经精神性亚组中逐步上调。
- 在神经精神性患者中,弥漫性综合征与氧化磷酸化模块正相关,而抗磷脂抗体阳性的神经精神性患者经无监督分析未与特定特征相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The management of neuropsychiatric systemic lupus erythematosus (NPSLE) remains challenging because of clinical heterogeneity and the complexity of pathophysiologic mechanisms involved. We sought to determine the molecular signature of NPSLE and its endotypes towards novel biomarkers and targeted therapies. METHODS: Whole-blood RNA sequencing from 308 patients with systemic lupus erythematosus (119 with NPSLE, 189 non-NPSLE) and 72-matched healthy controls (HCs) were performed. Supervised pathway enrichment analysis and unsupervised weighted gene coexpression network analysis were applied to distinguish clinically and molecularly defined NPSLE endotypes. RESULTS: Compared with HCs, patients with NPSLE demonstrated dysregulation of adaptive immune responses along with upregulation of interleukin (IL)-1, IL-6, IL-17, and IL-12/IL-23 signalling pathways. The comparison between NPSLE and non-NPSLE groups revealed a robust upregulation of complement cascade, DNA damage response, adaptive immunity, and IL-1 and IL-6 signalling. Furthermore, active NPSLE exhibited a strong autophagy signature. The B cell and complement cascade signatures exhibited a gradual upregulation across the non-NPSLE, inactive NPSLE, and active NPSLE subgroups. Within NPSLE, diffuse syndromes correlated positively with the oxidative phosphorylation module, while antiphospholipid antibody-positive NPSLE was not associated with specific signatures by unsupervised analysis. NPSLE endotypes such as cognitive dysfunction, seizures, psychosis, and optic neuritis were associated with distinct transcriptomic signatures namely IL-6 signalling and leukocyte migration, DNA damage response, inflammation, and type-I interferon, respectively. CONCLUSIONS: The clinical heterogeneity of NPSLE appears to be associated with molecular diversity, with certain endotypes or syndromes exhibiting distinct gene signatures. Upregulation of adaptive immune response and complement cascade suggests that complement inhibitors and B cell-targeted therapies could be further explored in NPSLE.
引用
- Nikolopoulos D, Sentis G, Kitsios I, et al. Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus. Ann Rheum Dis. 2025. PMID: 40348638. doi:10.1016/j.ard.2025.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。